Dow Down 0.36% Nasdaq Down 0.53%

Endocyte, Inc. (ECYT)

-NMS
8.58 Up 0.03(0.35%) Sep 12, 4:00PM EDT
Prev Close:8.55
Open:8.58
Bid:8.38 x 1500
Ask:8.65 x 100
1y Target Est:13.80
Beta:0.98
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:8.40 - 8.88
52wk Range:5.91 - 33.70
Volume:1,861,721
Avg Vol (3m):1,303,120
Market Cap:356.50M
P/E (ttm):N/A
EPS (ttm):-0.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ECYT

Comparison

Symbol% ChgMkt Cap
ECYTUp 0.35%356.50M
NKTRUp 0.07%1.76B
RHHBYDown 0.54%249.37B
SNSSDown 1.88%441.83M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.54
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.09
Quarterly EPS Est (Sep-14) :-0.18
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its proprietary technology to create novel small molecule drug conjugates (SMDCs)... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback